ライフサイエンスコーパス: choroidal neovascularization

1 D OCT in 44% of the cases with no associated choroidal neovascularization.

2 ive cystoid macular edema or exacerbation of choroidal neovascularization.

3 e a strong risk factor in the development of choroidal neovascularization.

4 sumed Ocular Histoplasmosis Syndrome-related choroidal neovascularization.

5 fundus changes and potentially of subsequent choroidal neovascularization.

6 arization in vivo in a laser injury model of choroidal neovascularization.

7 f an atrophic scar at the fovea or following choroidal neovascularization.

8 255 treatment-naive patients with subfoveal choroidal neovascularization.

9 nd a larger increase in total lesion area of choroidal neovascularization.

10 s investigated in the laser-induced model of choroidal neovascularization.

11 of the photoreceptor outer segments (OS) to choroidal neovascularization.

12 y contributor to increased susceptibility to choroidal neovascularization.

13 and thus reduce vascular leakage and retinal-choroidal neovascularization.

14 fluorescence and the volume of laser-induced choroidal neovascularization.

15 each eye of WT and COX-2 null mice to induce choroidal neovascularization.

16 of reactive oxygen species, contributing to choroidal neovascularization.

17 ent in vitro and in a model of laser-induced choroidal neovascularization.

18 ischemic retinopathy (OIR) and laser-induced choroidal neovascularization.

19 acterized by drusen, geographic atrophy, and choroidal neovascularization.

20 VEGF-A secretion and angiogenic phenotype in choroidal neovascularization.

21 insight into the pathogenesis of corneal and choroidal neovascularization.

22 oxygen-induced retinopathy and laser-induced choroidal neovascularization.

23 the efficacy and safety of PDT for treating choroidal neovascularization.

24 d macular degeneration and other diseases of choroidal neovascularization.

25 r deposits, Bruch's membrane thickening, and choroidal neovascularization.

26 d in the most effective means of identifying choroidal neovascularization.

27 tion and the risks of retinal detachment and choroidal neovascularization.

28 MVECs suggest it may play a critical role in choroidal neovascularization.

29 F-induced subretinal neovascularization, and choroidal neovascularization.

30 ng choroidal vessels at the site of baseline choroidal neovascularization.

31 at is commonly misdiagnosed as disc edema or choroidal neovascularization.

32 n strongly implicated in the pathogenesis of choroidal neovascularization.

33 s, both normal and with macular degeneration/choroidal neovascularization.

34 tion of nitric oxide (NO) in macrophages and choroidal neovascularization.

35 2 as a novel therapeutic target for reducing choroidal neovascularization.

36 nd photoreceptors and can be associated with choroidal neovascularization.

37 fundus changes and potentially of subsequent choroidal neovascularization.

38 cterized by fibrous membrane formation after choroidal neovascularization.

39 al Best vitelliform dystrophy and unilateral choroidal neovascularization.

40 ), RPE disruption (77% vs 3%, P < .001), and choroidal neovascularization (16% vs 0%, P = .028).

41 larger increase in mean total lesion area of choroidal neovascularization (3.00 mm(2)) than eyes with

42 ed injury that was associated with increased choroidal neovascularization, a hallmark of advanced exu

43 Current treatments for choroidal neovascularization, a major cause of blindness

44 inal pigment epithelium (RPE) abnormalities, choroidal neovascularization, acquired vitelliform lesio

45 eposition of drusen-like material or aborted choroidal neovascularization adjacent to the natural bre

46 g of the macular choroid (affected or not by choroidal neovascularization), along with the significan

47 Likewise, mouse laser-induced choroidal neovascularization, an injury that involves LP

48 l fibrosis after regression of laser-induced choroidal neovascularization and a decrease in mesenchym

49 These retinal lesions can be associated with choroidal neovascularization and central serous choriore

50 suppress hemangiogenesis in mouse models of choroidal neovascularization and dermal wound healing in

51 eripapillary atrophy were also common, while choroidal neovascularization and Fuchs spot were rare.

52 Some patients also develop choroidal neovascularization and glaucoma.

53 ivo screening strategy with rodent models of choroidal neovascularization and iterative compound desi

54 oidal choroidal vasculopathy is a variant of choroidal neovascularization and neovascular age related

55 dels of neovascular pathology [laser-induced choroidal neovascularization and the very low density li

56 econd eye had angioid streaks complicated by choroidal neovascularization and underwent prior thermal

57 s of ocular neovascularization: laser injury choroidal neovascularization and VEGF-induced corneal ne

58 y criteria for CATT specified that eyes have choroidal neovascularization and visual acuity between 2

59 ot, myopic chorioretinal atrophy, and myopic choroidal neovascularization) and optic disc (optic nerv

60 cted data on VA, OCT changes, development of choroidal neovascularization, and length of follow-up.

61 They may represent an early sign of active choroidal neovascularization, and should prompt to early

62 hy developed in areas previously occupied by choroidal neovascularization, and the other 5 eyes had a

63 Four stage 3 eyes had associated choroidal neovascularization, and these eyes had 20/60 p

64 lial growth factor antagonists also suppress choroidal neovascularization, and transgenic expression

65 ng oxygen-induced retinopathy, laser-induced choroidal neovascularization, and transgenic mouse model

66 ere older age, VA of 20/40 or better, larger choroidal neovascularization area, presence of geographi

67 6.0 diopters with the presence of subretinal/choroidal neovascularization as indicated by Internation

68 models with deficient or spontaneous retinal/choroidal neovascularization, as well as models with ind

69 in ischemic retina and significantly reduced choroidal neovascularization at Bruch's membrane rupture

70 ent-naive patients also showed no detectable choroidal neovascularization at week 12 on fluorescein a

71 se vision than their mother, despite lacking choroidal neovascularization, because of the extent of p

72 ith UPR inhibitors or siRNAs reduced retinal/choroidal neovascularization by a further 25% to 40%, an

73 Digoxin suppresses retinal and choroidal neovascularization by reducing HIF-1alpha leve

74 ells (HSCs) have been shown to contribute to choroidal neovascularization by signaling through the SD

75 In age-related macular degeneration, choroidal neovascularization can be observed without the

76 rly onset macular degenerative disease, with choroidal neovascularization causing a loss of vision in

77 risk of scarring were predominantly classic choroidal neovascularization (CNV) (aHR, 3.1; CI, 2.4-3.

78 ociations between all rare pLoF variants and choroidal neovascularization (CNV) (OR, 1.34; 95% CI, 1.

79 Baseline occult-type choroidal neovascularization (CNV) (P = .0156) and retin

80 the mechanism of cell death in laser-induced choroidal neovascularization (CNV) after photodynamic th

81 peptide fragments on vessel sprouting and on choroidal neovascularization (CNV) after subconjunctival

82 if they had low vision in the fellow eye and choroidal neovascularization (CNV) along with (1) no res

83 lemonitoring for early detection of incident choroidal neovascularization (CNV) among patients with a

84 Choroidal neovascularization (CNV) and capillary dilatio

85 Inflammation and immune cells regulate choroidal neovascularization (CNV) and could become ther

86 gamma-secretase could inhibit laser-induced choroidal neovascularization (CNV) and if this was assoc

87 glia and macrophages play a critical role in choroidal neovascularization (CNV) and may, therefore, b

88 in two in vivo murine models, laser-induced choroidal neovascularization (CNV) and melanoma growth.

89 Wet AMD includes typical choroidal neovascularization (CNV) and polypoidal choroi

90 Eyes with advanced choroidal neovascularization (CNV) and poor visibility o

91 s investigated the effects of doxycycline on choroidal neovascularization (CNV) and regulation of MMP

92 age-related macular degeneration-associated choroidal neovascularization (CNV) and VA between 20/25

93 cting and quantifying experimentally induced choroidal neovascularization (CNV) and vascular changes

94 .96 to 0.97 for quantitative measurements of choroidal neovascularization (CNV) area and total area o

95 Total choroidal neovascularization (CNV) area increased by 1.1

96 cholesterolemia, worse visual acuity, larger choroidal neovascularization (CNV) area, retinal angioma

97 on methods that are used to detect new-onset choroidal neovascularization (CNV) as a result of age-re

98 s to develop and characterize a rat model of choroidal neovascularization (CNV) as occurs in age-rela

99 es of previously untreated, active subfoveal choroidal neovascularization (CNV) associated with AMD w

100 l (ie, ocular) complement factor H (CFH) and choroidal neovascularization (CNV) associated with wet a

101 The mean VA and the type of the choroidal neovascularization (CNV) at the start of treat

102 The relative risk for choroidal neovascularization (CNV) based on drusen area,

103 Choroidal neovascularization (CNV) can complicate AMD an

104 In the eye, choroidal neovascularization (CNV) causes blindness in p

105 wever, these mice develop significantly less choroidal neovascularization (CNV) compared to wild-type

106 ace changes over time and their influence on choroidal neovascularization (CNV) development.

107 of fluorescein angiograms from patients with choroidal neovascularization (CNV) due to age-related ma

108 also called FLT1), in patients with blinding choroidal neovascularization (CNV) from age-related macu

109 to identify patients with exudative AMD and choroidal neovascularization (CNV) in 1 or both eyes res

110 suppress retinal vessel leakage and inhibit choroidal neovascularization (CNV) in a laser-induced CN

111 flammation have been implicated in promoting choroidal neovascularization (CNV) in age-related macula

112 Choroidal neovascularization (CNV) in age-related macula

113 ibitor of pathological angiogenesis, such as choroidal neovascularization (CNV) in age-related macula

114 raphy angiography (OCTA) in the detection of choroidal neovascularization (CNV) in age-related macula

115 s deciphering the transcriptional profile of choroidal neovascularization (CNV) in body donor eyes wi

116 study, we describe a new method for inducing choroidal neovascularization (CNV) in C57BL/6 mice, an a

117 tients in Proxima A had bilateral GA without choroidal neovascularization (CNV) in either eye (N = 29

118 acteristics and natural history of quiescent choroidal neovascularization (CNV) in geographic atrophy

119 macular edema (DME), retinal vein occlusion, choroidal neovascularization (CNV) in high myopia, and o

120 ) has been implicated in the pathogenesis of choroidal neovascularization (CNV) in neovascular AMD, w

121 Choroidal neovascularization (CNV) in pregnancy has rare

122 nhibitor, 10 weeks post-injection suppresses choroidal neovascularization (CNV) in rats.

123 ified: GA in both eyes (GA:GA); GA in 1 eye, choroidal neovascularization (CNV) in the fellow eye (GA

124 low eye statuses were analyzed: (1) no GA or choroidal neovascularization (CNV) in the fellow eye, (2

125 ry outcome measure was time to occurrence of choroidal neovascularization (CNV) in the study eye.

126 cell adhesion and proliferation in vitro and choroidal neovascularization (CNV) in vivo was examined.

127 Adjacent to active choroidal neovascularization (CNV) in wet AMD, CC dropou

128 al active Rap1a expression and inhibition of choroidal neovascularization (CNV) induced by laser inju

129 Choroidal neovascularization (CNV) is a defining feature

130 Choroidal neovascularization (CNV) is a major cause of v

131 Choroidal neovascularization (CNV) is a major cause of v

132 Choroidal neovascularization (CNV) is a prevalent cause

133 Choroidal neovascularization (CNV) is a severe complicat

134 Laser-induced choroidal neovascularization (CNV) is a widely used mode

135 Choroidal neovascularization (CNV) is the major cause of

136 Myopic choroidal neovascularization (CNV) is the most common si

137 Choroidal neovascularization (CNV) leads to loss of visi

138 luded lower BCVA, younger age, smaller total choroidal neovascularization (CNV) leakage area, smaller

139 change in angiographic total lesion size and choroidal neovascularization (CNV) lesion size.

140 Eyes with subfoveal choroidal neovascularization (CNV) lesions had a lower g

141 onstrated by increased size of laser-induced choroidal neovascularization (CNV) lesions.

142 AMG 386 was tested in a laser-induced choroidal neovascularization (CNV) model in monkeys usin

143 In the laser-induced choroidal neovascularization (CNV) model, the CNV area w

144 treatment/intervention modality of the laser choroidal neovascularization (CNV) model, the efficacy o

145 tion of laser rupture of Bruch's membrane, a choroidal neovascularization (CNV) model.

146 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) models.

147 he corneal micropocket and the laser-induced choroidal neovascularization (CNV) mouse models.

148 Choroidal neovascularization (CNV) of the macular area o

149 were subdivided into 3 groups: eyes without choroidal neovascularization (CNV) or chorioretinal atro

150 s with AMD with severe atrophy due to either choroidal neovascularization (CNV) or geographic atrophy

151 degeneration (AMD) to the advanced stages of choroidal neovascularization (CNV) or geographic atrophy

152 lantation of 7KCh-exposed microglia promoted choroidal neovascularization (CNV) relative to control m

153 ty required angiographic and OCT evidence of choroidal neovascularization (CNV) secondary to age-rela

154 Patients with subfoveal choroidal neovascularization (CNV) secondary to AMD were

155 ty of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization (CNV) Secondary to AMD, Pro

156 A total of 151 patients with subfoveal choroidal neovascularization (CNV) secondary to neovascu

157 DRS letters, angiographic total lesion size, choroidal neovascularization (CNV) size, and optical coh

158 was an 85.5% mean reduction from baseline in choroidal neovascularization (CNV) size.

159 In contrast to the choroidal neovascularization (CNV) subtype, the genetic

160 ecrosis factor (TNF)-alpha has been found in choroidal neovascularization (CNV) surgically removed fr

161 was more prominent in patients with classic choroidal neovascularization (CNV) than those with occul

162 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) to assess the contrib

163 Choroidal neovascularization (CNV) was manually segmente

164 ither pericytes or astrocytes, laser-induced choroidal neovascularization (CNV) was significantly red

165 corneal neovascularization and laser-induced choroidal neovascularization (CNV) were examined in TIMP

166 tinopathy (OIR) model and the laser model of choroidal neovascularization (CNV) were used to test the

167 es are the main infiltrating immune cells in choroidal neovascularization (CNV), a hallmark of the hu

168 t epithelium derived factor (PEDF) may cause choroidal neovascularization (CNV), a key event in wet A

169 To investigate the genetic contribution to choroidal neovascularization (CNV), a leading cause of b

170 The molecular pathogenesis of choroidal neovascularization (CNV), an angiogenic proces

171 play an important role in the development of choroidal neovascularization (CNV), an integral componen

172 Older age, larger area of choroidal neovascularization (CNV), and elevation of ret

173 data from retinas treated with laser-induced choroidal neovascularization (CNV), bright white-light e

174 In 2 eyes with secondary choroidal neovascularization (CNV), distinct en face SS-

175 normal growth of choroidal blood vessels, or choroidal neovascularization (CNV), is a hallmark of the

176 t epithelium derived factor (PEDF) may cause choroidal neovascularization (CNV), key event of wet AMD

177 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV), mimicking hypoxia-me

178 permeability, while there was no evidence of choroidal neovascularization (CNV).

179 were also more susceptible to laser-induced choroidal neovascularization (CNV).

180 ibodies within retinal lesions in a model of choroidal neovascularization (CNV).

181 s ligand (FasL) function in a mouse model of choroidal neovascularization (CNV).

182 ing hyperreflective material consistent with choroidal neovascularization (CNV).

183 ch's membrane (BrM) into the retina, forming choroidal neovascularization (CNV).

184 that occur in vivo during the development of choroidal neovascularization (CNV).

185 he wet form of the disease, characterized by choroidal neovascularization (CNV).

186 AMD-related vision loss, is characterized by choroidal neovascularization (CNV).

187 plex using the murine model of laser-induced choroidal neovascularization (CNV).

188 ith AMD also lose vision as a consequence of choroidal neovascularization (CNV).

189 ive B6-gld mice were laser treated to induce choroidal neovascularization (CNV).

190 cular degeneration (AMD) is characterized by choroidal neovascularization (CNV).

191 imens from mice treated with laser to induce choroidal neovascularization (CNV).

192 tance of PLCgamma1 and c-Cbl in experimental choroidal neovascularization (CNV).

193 to sites of complement activation, in mouse choroidal neovascularization (CNV).

194 MD, including an increased susceptibility to choroidal neovascularization (CNV).

195 ay have a permissive effect on the growth of choroidal neovascularization (CNV).

196 e retina, an abnormality also referred to as choroidal neovascularization (CNV).

197 ted the role of nAChR in the pathogenesis of choroidal neovascularization (CNV).

198 ay plays a central role in the laser-induced choroidal neovascularization (CNV).

199 te AMD subtypes; geographic atrophy (GA) and choroidal neovascularization (CNV).

200 ous proliferation (RAP) lesions, and classic choroidal neovascularization (CNV).

201 ent white dot syndrome (MEWDS) who developed choroidal neovascularization (CNV).

202 of irreversible blindness and manifests with choroidal neovascularization (CNV).

203 cular degeneration (AMD) is characterized by choroidal neovascularization (CNV).

204 drusen; retinal pigment epithelial changes; choroidal neovascularization (CNV); atrophy; and hypoaut

205 nfidence interval [CI], 53-442), followed by choroidal neovascularization (CNV; OR, 90; 95% CI, 26-31

206 use of intravitreal anti-VEGF for traumatic choroidal neovascularizations (CNV).

207 features from pathologic RPE detachments and choroidal neovascularizations (CNVs).

208 had reduced dihydroethidium fluorescence and choroidal neovascularization compared with wild-type con

209 Choroidal neovascularization developed in 1 eye in the P

210 Bilateral choroidal neovascularization developed in only 1 patient

211 Patients (N = 1817) with untreated, active choroidal neovascularization due to age-related macular

212 ed from 1134 of 1146 patients with subfoveal choroidal neovascularization due to AMD with minimally c

213 Cs suggests a possible role for potentiating choroidal neovascularization during the pathology of neo

214 cious in mouse models of geographic atrophy, choroidal neovascularization, graft-versus-host disease,

215 ous in vivo systems, including laser-induced choroidal neovascularization, growth factor-induced corn

216 Stage 3 eyes without choroidal neovascularization had a mean presenting visua

217 betic macular edema, retinal vein occlusion, choroidal neovascularization) have shown promising resul

218 Areas of geographic atrophy and choroidal neovascularization imaged by FA were depicted

219 al neovascularization in 3 eyes and inactive choroidal neovascularization in 1 eye.

220 silar insufficiency in 2.8% of eyes; non-AMD choroidal neovascularization in 2.3% of eyes; retinitis

221 f a hyperflow signal corresponding to active choroidal neovascularization in 3 eyes and inactive chor

222 pressed initiation and growth of spontaneous choroidal neovascularization in a mouse model, and the c

223 fied as a risk factor for the development of choroidal neovascularization in age-related macular dege

224 , and is likely to play an important role in choroidal neovascularization in age-related macular dege

225 s, retinal vascular leakage, and retinal and choroidal neovascularization in animal models of ROP and

226 ithout evidence of or previous treatment for choroidal neovascularization in either eye and best-corr

227 EGF signaling exists and may be important in choroidal neovascularization in human age-related macula

228 sunitinib microparticles potently suppresses choroidal neovascularization in mice for six months and

229 travitreal administration of oligo G reduces choroidal neovascularization in mice.

230 ote various pathologic conditions, including choroidal neovascularization in models of neovascular ag

231 s showed excellent short-term suppression of choroidal neovascularization in patients with exudative

232 aditional multimodal imaging, helps diagnose choroidal neovascularization in patients with Malattia L

233 lipsoid zone disruption, RPE disruption, and choroidal neovascularization in peripapillary combined h

234 ies demonstrated that aflibercept suppresses choroidal neovascularization in several animal models.

235 We used a laser-injury wound model of choroidal neovascularization in the eye to determine the

236 yes and retinal hemorrhages with an apparent choroidal neovascularization in the left eye, which was

237 n, the authors used a model of laser-induced choroidal neovascularization in the mouse eye and invest

238 reduce pro-angiogenic isoforms, and prevent choroidal neovascularization in vivo.

239 red for endothelial cell growth in vitro and choroidal neovascularization in vivo.

240 efined as HM with the presence of subretinal/choroidal neovascularization indicated by the ICD-9-CM d

241 Subsequent choroidal neovascularization is limited to the area dema

242 ted macular degeneration eyes with subfoveal choroidal neovascularization is uniform across a wide ra

243 inistration of IL-4 attenuates laser-induced choroidal neovascularization (L-CNV) due to specific IL-

244 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (LCNV).

245 The pattern of choroidal neovascularization lesion size enlargement in

246 The main determinant of choroidal neovascularization lesion size enlargement is

247 Pigmented mice with laser-induced choroidal neovascularization lesions (n = 7 eyes) were a

248 e first realistic means to address subfoveal choroidal neovascularization lesions from age-related ma

249 ed BRB leakage and the size of laser-induced choroidal neovascularization lesions.

250 ffect on both area and number of spontaneous choroidal neovascularization lesions.

251 ctional role for TLR2 in the pathogenesis of choroidal neovascularization, likely by promoting inflam

252 Choroidal neovascularization location as well as retinal

253 outcomes in eyes with treatment-naive myopic choroidal neovascularization (mCNV) in the United States

254 Furthermore, analysis in a laser-induced choroidal neovascularization model showed that depletion

255 nd showed good efficacy in the laser induced choroidal neovascularization model.

256 ssel growth were also determined in a murine choroidal neovascularization model.

257 pathological angiogenesis in a laser-induced choroidal neovascularization mouse model.

258 or ATF6 in the oxygen-induced retinopathy or choroidal neovascularization mouse models caused an appr

259 inal hemorrhage (n = 3, 0.9%), active myopic choroidal neovascularization (n = 3, 0.9%), and no case

260 Retinal and choroidal neovascularization (NV) and vascular leakage c

261 In contrast, choroidal neovascularization occurred equally well in bi

262 Stage 3 resembles occult choroidal neovascularization, occurs primarily in older

263 d associations of ARMS2 and CFH with type of choroidal neovascularization on fluorescein angiography

264 ioretinopathy, and did not have a history of choroidal neovascularization or photodynamic therapy.

265 -related macular degeneration independent of choroidal neovascularization or retinal pigment epitheli

266 95% CI, 1.35-6.08; P = .006), larger area of choroidal neovascularization (OR for a >4-disc area vs <

267 l loss may occur during a preoccult phase of choroidal neovascularization, prior to the development o

268 inal vasculitis, multifocal choroiditis, and choroidal neovascularization, providing for the first ti

269 r of patients with treatment-naive subfoveal choroidal neovascularization receiving intravitreal rani

270 n 2 (12%), a dome-shaped macula in 1 (6%), a choroidal neovascularization-related subretinal scar in

271 retinal angiomatous proliferation, and mixed choroidal neovascularization, respectively.

272 ow, the most common form of late-stage AMD - choroidal neovascularization - responds to treatment wit

273 lar Endothelial Growth Factor in Age-Related Choroidal Neovascularization) results were not released

274 en-label study in 15 patients with subfoveal choroidal neovascularization secondary to AMD at a clini

275 l Neovascularization with or without Classic Choroidal Neovascularization Secondary to AMD Study), wh

276 participants, aged >/=50 years, with active choroidal neovascularization secondary to AMD.

277 For choroidal neovascularization secondary to inflammatory d

278 escein-negative intraretinal cystic changes, choroidal neovascularization, serous retinal elevations

279 photoreceptor degeneration, and exaggerated choroidal neovascularization similar to AMD.

280 mL vs 69.3 pg/mL) and did not correlate with choroidal neovascularization size and lesion type.

281 In the B50 group, choroidal neovascularization size was smaller (0.73 vs 1

282 ular Degeneration: Detection of Onset of new Choroidal neovascularization Study (AMD DOC Study) evalu

283 f visual acuity, on average, at detection of choroidal neovascularization than do individuals using s

284 pegaptanib sodium and PDT on lesion size in choroidal neovascularization than with each monotherapy.

285 The mother had choroidal neovascularization that was treated with bevac

286 giogenic isoforms of VEGF-A as inhibitors of choroidal neovascularization, the authors used a model o

287 in angiograms and OCT images were graded for choroidal neovascularization type.

288 Choroidal neovascularization was diagnosed in 8 of 27 ey

289 tioned CD200R(-/-) BMMPhi, and laser-induced choroidal neovascularization was enhanced in CD200R-defi

290 Choroidal neovascularization was generated by laser inju

291 Choroidal neovascularization was generated in mice using

292 8; P = 0.0005), and more visits at which the choroidal neovascularization was graded as active (OR, 1

293 Choroidal neovascularization was induced by 532-nm diode

294 No signs of choroidal neovascularization were observed.

295 ralizing protein can result in regression of choroidal neovascularization, which is sometimes associa

296 itreal morpholino injection suppressed laser choroidal neovascularization while increasing sKDR.

297 Parstatin potently inhibited choroidal neovascularization with an IC(50) of approxima

298 detachment associated with occult subfoveal choroidal neovascularization with intravitreal ranibizum

299 ty of Ranibizumab in Subjects with Subfoveal Choroidal Neovascularization with or without Classic Cho

300 8(-/-)Abca4(-/-) mice for 4 months prevented choroidal neovascularization without changing retinal VE